Allarity Therapeutics (ALLR) Other Working Capital Changes (2020 - 2022)
Allarity Therapeutics' (ALLR) quarterly Other Working Capital Changes came in at $26000.0 in Q2 2022, up 8.33% YoY from $24000.0 in Q2 2021, and little changed on a QoQ basis from $26000.0 in Q1 2022.
Allarity Therapeutics (ALLR) Other Working Capital Changes (2020 - 2022) Analysis & Trends
Allarity Therapeutics (ALLR) has 3 years of Other Working Capital Changes data on file, last reported at $26000.0 in Q2 2022.
- Quarterly Other Working Capital Changes rose 8.33% year-over-year to $26000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $242000.0 (changed N/A YoY) and the FY2024 annual result came in at $207000.0, up 2687.5% from the prior year.
- Other Working Capital Changes was little changed at $26000.0 in Q2 2022, from $26000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q4 2022 to a low of -$820000.0 in Q4 2023.
- A 5-year average of -$22000.0 and a median of -$3000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes slipped 5.26% — and 2022, when it grew 8.33%.
- Tracing ALLR's Other Working Capital Changes over 3 years: stood at $95000.0 in 2020, then decreased by 5.26% to $90000.0 in 2021, then sank by 71.11% to $26000.0 in 2022.
- The last three Other Working Capital Changes figures came in at $26000.0 (Q2 2022), $26000.0 (Q1 2022), and $90000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 95,000.00 |
| Dec 31, 2020 | 95,000.00 |